COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients

Clinical trial NCT05054218 · COMPLETED

Trial details

NCT number: NCT05054218
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Covid19 SARS-CoV2 Infection

Start date: 2021-09-10
Primary completion: 2022-07-16
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.